| pubmed-article:1835680 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1835680 | lifeskim:mentions | umls-concept:C0015127 | lld:lifeskim |
| pubmed-article:1835680 | lifeskim:mentions | umls-concept:C1314792 | lld:lifeskim |
| pubmed-article:1835680 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:1835680 | lifeskim:mentions | umls-concept:C1555029 | lld:lifeskim |
| pubmed-article:1835680 | lifeskim:mentions | umls-concept:C0162337 | lld:lifeskim |
| pubmed-article:1835680 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:1835680 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:1835680 | pubmed:dateCreated | 1992-1-7 | lld:pubmed |
| pubmed-article:1835680 | pubmed:abstractText | To examine the effect of plasminogen activator therapy on vascular permeability, we used a modified rabbit mesenteric model of extravascular tissue accumulation of radiolabeled albumin. | lld:pubmed |
| pubmed-article:1835680 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1835680 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:1835680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1835680 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1835680 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1835680 | pubmed:issn | 0009-7322 | lld:pubmed |
| pubmed-article:1835680 | pubmed:author | pubmed-author:GeorgeDD | lld:pubmed |
| pubmed-article:1835680 | pubmed:author | pubmed-author:LoscalzoJJ | lld:pubmed |
| pubmed-article:1835680 | pubmed:author | pubmed-author:WareJ AJA | lld:pubmed |
| pubmed-article:1835680 | pubmed:author | pubmed-author:RabbaniL ELE | lld:pubmed |
| pubmed-article:1835680 | pubmed:author | pubmed-author:RuddM AMA | lld:pubmed |
| pubmed-article:1835680 | pubmed:author | pubmed-author:JohnstoneM... | lld:pubmed |
| pubmed-article:1835680 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1835680 | pubmed:volume | 84 | lld:pubmed |
| pubmed-article:1835680 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1835680 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1835680 | pubmed:pagination | 2568-73 | lld:pubmed |
| pubmed-article:1835680 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:meshHeading | pubmed-meshheading:1835680-... | lld:pubmed |
| pubmed-article:1835680 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1835680 | pubmed:articleTitle | Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin. | lld:pubmed |
| pubmed-article:1835680 | pubmed:affiliation | Cardiology Division, Brigham and Women's Hospital, Boston, MA 02115. | lld:pubmed |
| pubmed-article:1835680 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1835680 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1835680 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
